Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record.

Optimization of Fibronectin-Assisted Retroviral Gene Transfer into Human CD34 + Hematopoietic Cells

Hanenberg, Helmut, Hashino, Kimikazu, Konishi, Haruko, Hock, Randy A., Kato, Ikunoshin, Williams, David A. · 1997 · Human Gene Therapy

Abstract

Efficient retroviral gene transfer into hematopoietic stem and progenitor cells can be achieved by co-localizing retrovirus and target cells on specific adhesion domains of recombinant fibronectin (FN) fragments. In this paper, we further optimize this technology for human CD34+ cells. Investigating the role of cytokine prestimulation in retrovirus-mediated gene transfer on plates coated with the recombinant FN CH-296 revealed that prestimulation of granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood (PB) CD34+ cells was essential to achieve efficient gene transfer into clonogenic cells. The highest gene transfer occurred by prestimulating PB CD34+ cells for 40 hr with a combination of stem cell factor (SCF), G-CSF, and megakaryocyte growth and development factor (MGDF) prior to retroviral infection on CH-296. Surprisingly, a prolonged simultaneous exposure of primary CD34+ PB cells to retrovirus and cytokines in the presence of CH-296 lowered the gene transfer efficiency. Gene transfer into cytokine prestimulated CD34+ bone marrow (BM) cells was not influenced by increasing the coating concentrations of a recombinant FN fragment, CH-296, nor was it adversely influenced by increasing the number of CD34+ target cells, suggesting that the amount of retroviral particles present in the supernatant was not a limiting factor for transduction of CD34+ BM cells on CH-296-coated plates. The polycation Polybrene was not required for efficient transduction of hematopoietic cells in the presence of CH-296. Furthermore, we demonstrated that repeated exposure of CH-296 to retrovirus containing supernatant, called preloading, can be employed to concentrate the amount of retroviral particles bound to CH-296. These findings establish a simple and short clinically applicable transduction protocol that targets up to 68% of BM or G-CSF-mobilized PB CD34+ cells and is capable of genetically modifying up to 17% of CD34+CD38–/dim PB cells. Fibronectin-assisted retroviral gene transfer greatly enhances the transduction of mammalian cells adherent to specific adhesion domains of fibronectin. Here, we developed a clinically applicable transduction protocol that reproducibly demonstrated high-efficiency gene transfer into hematopoietic CD34+ cells from bone marrow or cytokine-mobilized peripheral blood. The approach to target hematopoietic progenitor cells may be useful in human gene therapy applications, particularly where correction of a genetic deficiency is not required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.1997.8.18-2193

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 196

Metadata

Authors
Hanenberg, H., Hashino, K., Konishi, H., Hock, R. A., Kato, I., & Williams, D. A.
Venue
Human Gene Therapy
Published
1997-12-10
Volume
8
Issue
18
Pages
2193-2206
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2082795668
Cited by
196
References
0
FWCI
9.67
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optimization of Fibronectin-Assisted Retroviral Gene Transfer into Human CD34 + Hematopoietic Cells. https://app.cochat.ai/papers/10.1089/hum.1997.8.18-2193
The paper
Hanenberg, H., Hashino, K., Konishi, H., Hock, R. A., Kato, I., & Williams, D. A. (1997). Optimization of Fibronectin-Assisted Retroviral Gene Transfer into Human CD34 + Hematopoietic Cells. Human Gene Therapy. https://doi.org/10.1089/hum.1997.8.18-2193

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.